Sign In
23 May 2016 16:03
23 May 2016
RECKITT BENCKISER GROUP PLC
DIRECTOR/PDMR SHAREHOLDINGS
Reckitt Benckiser Group plc (the "Company" or "RB") announces the following changes in the interests of Directors and Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
The remuneration of RB's Non-Executive Directors includes fees which are to be used in the purchase of Shares. Each of the Non-Executive Directors of the Company listed below receives approximately 18% of their base fee in the form of Shares, which they are expected to retain for the duration of their tenure.
The Company was notified on 23 May 2016 that in this respect Shares were acquired on 20 May 2016 on the London Stock Exchange at a price of £68.42 per share. The number of Shares purchased in respect of each Director was as follows:
Name | Number of Shares |
Adrian Bellamy | 616 |
André Lacroix | 124 |
Kenneth Hydon | 129 |
Judith Sprieser | 131 |
Nicandro Durante | 124 |
Mary Harris | 135 |
Pam Kirby | 124 |
Chris Sinclair | 188 |
Warren Tucker* | 183 |
* shares will be registered in the name of his spouse, Katherine Victoria Tucker.
The Company was also notified on 23 May 2016 that Mary Harris, Non-Executive Director, purchased an additional 1,457 Shares on 23 May 2016 at a price of £68.12 per share.
Following the transactions detailed above, the total beneficial holdings of each of the Directors noted above are as shown below:
Name |
Number of Shares | Percentage of Issued Share Capital (excl Treasury Shares) |
Adrian Bellamy | 24,915 | 0.00353% |
André Lacroix | 2,672 | 0.00038% |
Kenneth Hydon | 5,946 | 0.00084% |
Judith Sprieser | 4,264 | 0.00060% |
Nicandro Durante | 323 | 0.00005% |
Mary Harris | 1,729 | 0.00025% |
Pam Kirby | 3,190 | 0.00045% |
Chris Sinclair | 324 | 0.00005% |
Warren Tucker | 2,200 | 0.00031% |
For further Information:Christine Logan
Company SecretaryTel +44 (0) 1753 217 800
Richard Joyce
SVP, Investor Relations, Communications & External Affairs
Tel. +44 (0)1753 217 800
About RB:
RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.
Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.
RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of companies
Follow the stocks
